)
Rohtash Kumar, PhD
Head of CDMO, Small and Large Molecule
Syngene
Rohtash is an established pharmaceutical operations leader with over two decades of experience in R&D, manufacturing, and executive leadership across global CDMO organizations. His career includes significant roles at renowned companies such as Bachem Americas, Sigma Aldrich, and Apotex. Most recently, he led Global Technology and Development at Veranova, where he drove innovation in APIs, including small molecules, peptides, oligonucleotides, and biologics. His efforts successfully advanced branded API molecules to market in collaboration with biotech partners, showcasing his ability to bridge the gap between research and commercialization.
A prolific researcher, Rohtash holds multiple patents and publications to his name. He earned his Ph.D. in Organic Chemistry from the University of Delhi, an M.Sc in Organic Chemistry, and an MBA from Chaudhary Charan Singh University. Additionally, he is a member of the American, Canadian, and Indian Medical Societies.
Sessions
-
23-Jun-2026BioProcess TheatreBioProcess Insider Focus
-
23-Jun-2026BioProcess TheatreBiologics Breakthrough: Cutting Costs While Expanding Global Reach
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}